APA Alıntı

Hollestelle, A., van der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., . . . Goode, E. L. (2015). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol.

Chicago Stili Alıntı

Hollestelle, Antoinette, et al. "No Clinical Utility of KRAS Variant Rs61764370 for Ovarian or Breast Cancer." Gynecol Oncol 2015.

MLA Alıntı

Hollestelle, Antoinette, et al. "No Clinical Utility of KRAS Variant Rs61764370 for Ovarian or Breast Cancer." Gynecol Oncol 2015.